DHEA and cognitive function in the elderly

Journal of Steroid Biochemistry and Molecular Biology

Volumn 145, Issue , 2015, Pages 281-292

  Maggio, Marcello ^a,b   De Vita, Francesca ^a   Fisichella, Alberto ^a   Colizzi, Elena ^a   Provenzano, Sandra ^a   Lauretani, Fulvio ^a   Luci, Michele ^a   Ceresini, Graziano ^a,b   Dall'Aglio, Elisabetta ^b   Caffarra, Paolo ^b,c   Valenti, Giorgio ^b   Ceda, Gian Paolo ^a,b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c AUSL   (Italy)

Author keywords

Cognitive function; DHEA; Older subjects

Indexed keywords

HYDROCORTISONE; PRASTERONE; PRASTERONE SULFATE; STEROID;

ACUTE STRESS; AGED; CEREBROSPINAL FLUID; CLINICAL TRIAL (TOPIC); COGNITION; DEMENTIA; DRUG EFFECT; FEMALE; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPROTECTION; NONHUMAN; POSTMENOPAUSE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ADULT; ANIMAL; BRAIN; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; OBSERVATIONAL STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BRAIN; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DEMENTIA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBSERVATIONAL STUDY AS TOPIC; POSTMENOPAUSE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEROIDS;

EID: 84915789115     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.03.014     Document Type: Review

References (137)

1. W.E. Rainey, B.R. Carr, H. Sasano, T. Suzuki, and J.I. Mason Dissecting human adrenal androgen production Trends Endocrinol. Metab. 13 2002 234 239
2. J.F. Dunn, B.C. Nisula, and D. Rodbard Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma J. Clin. Endocrinol. Metab. 53 1981 58 68
3. P.J. Hornsby Aging of the human adrenal cortex Ageing Res. Rev. 1 2002 229 242
4. F. Labrie Intracrinology Mol. Cell Endocrinol. 78 1991 C113 C118
5. A.W. Meikle, R.A. Daynes, and B.A. Araneo Adrenal androgen secretion and biologic effects Endocrinol. Metab. Clin. North Am. 20 1991 381 400
6. E.R. Simpson, and S.R. Davis Minireview: aromatase and the regulation of estrogen biosynthesis - some new perspectives Endocrinology 142 2001 4589 4594
7. F. Labrie, V. Luu-The, S.X. Lin, J. Simard, and C. Labrie Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues Trends Endocrinol. Metab. 11 2000 421 427
8. J.C. Havelock, R.J. Auchus, and W.E. Rainey The rise in adrenal androgen biosynthesis: adrenarche Semin. Reprod. Med. 22 2004 337 347
9. N. Orentreich, J.L. Brind, R.L. Rizer, and J.H. Vogelman Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J. Clin. Endocrinol. Metab. 59 1984 551 555
10. G. Ceresini, S. Morganti, I. Rebecchi, M. Freddi, G.P. Ceda, A. Banchini, S.B. Solerte, E. Ferrari, F. Ablondi, and G. Valenti Evaluation of the circadian profiles of serum dehydroepiandrosterone (DHEA), cortisol, and cortisol/DHEA molar ratio after a single oral administration of DHEA in elderly subjects Metabolism 49 2000 548 551
11. H. Nawata, T. Yanase, K. Goto, T. Okabe, and K. Ashida Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S Mech. Ageing Dev. 123 2002 1101 1106
12. M. Ohashi, K. Kato, H. Nawata, and H. Ibayashi Adrenocortical responsiveness to graded ACTH infusions in normal young and elderly human subjects Gerontology 32 1986 43 51
13. F.S. Salek, K.L. Bigos, and P.D. Kroboth The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies J. Clin. Pharmacol. 42 2002 247 266
14. Z. Barrou, P. Charru, and C. Lidy Dehydroepiandrosterone (DHEA) and aging Arch. Gerontol. Geriatr. 24 1997 233 241
15. D. Liu, and J.S. Dillon Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3) Biol. Chem. 77 2002 21379 21388
16. A.W. Meikle, R.W. Dorchuck, B.A. Araneo, J.D. Stringham, T.G. Evans, S.L. Spruance, and R.A. Daynes The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells J. Steroid Biochem. Mol. Biol. 42 1992 293 304
17. J.M. Bruder, L. Sobek, and M. Oettel Dehydroepiandrosterone stimulates the estrogen response element J. Steroid Biochem. Mol. Biol. 62 1997 461 466
18. S. Chalbot, and R. Morfin Dehydroepiandrosterone metabolites and their interactions in humans Drug Metabol. Drug Interact. 22 2006 1 23
19. K. Tsuji, D. Furutama, M. Tagami, and N. Ohsawa Specific binding and effects of dehydroepiandrosterone sulfate (DHEA-S) on skeletal muscle cells: possible implication for DHEA-S replacement therapy in patients with myotonic dystrophy Life Sci. 65 1999 17 26
20. M.R. Williams, S. Ling, T. Dawood, K. Hashimura, A. Dai, H. Li, J.P. Liu, J.W. Funder, K. Sudhir, and P.A. Komesaroff Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs J. Clin. Endocrinol. Metab. 87 2002 176 181
21. T. Simoncini, P. Mannella, L. Fornari, G. Varone, A. Caruso, and A.R. Genazzani Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms Endocrinology 144 2003 3449 3455
22. S. Demirgören, M.D. Majewska, C.E. Spivak, and E.D. London Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor Neuroscience 45 1991 127 135
23. T. Suzuki, N. Suzuki, R.A. Daynes, and E.G. Engleman Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells Clin. Immunol. Immunopathol. 61 1991 202 211
24. E.E. Baulieu Neurosteroids: a novel function of the brain Psychoneuroendocrinology 23 1998 963 987
25. E.E. Benarroch Neurosteroids: endogenous modulators of neuronal excitability and plasticity Neurology 68 2007 945 947
26. P.A. Lapchak, and D.M. Araujo Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases Int. Rev. Neurobiol. 46 2001 379 397
27. H. Li, G. Klein, P. Sun, and A.M. Buchan Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia Brain Res. 888 2001 263 266
28. K. Kurata, M. Takebayashi, S. Morinobu, and S. Yamawaki beta-estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-d-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms J. Pharmacol. Exp. Ther. 311 2004 237 245
29. N.A. Compagnone, and S.H. Mellon Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development Proc. Nat. Acad. Sci. U.S.A. 95 1998 4678 4683
30. T. Hajszan, N.J. MacLusky, and C. Leranth Dehydroepiandrosterone increases hippocampal spine synapse density in ovariectomized female rats Endocrinology 145 2004 1042 1045
31. G.J. Brewer, J. Espinosa, M.P. McIlhaney, T.P. Pencek, J.P. Kesslak, C. Cotman, J. Viel, and D.C. McManus Culture and regeneration of human neurons after brain surgery J. Neurosci. Methods 107 2001 15 23
32. K.K. Karishma, and J. Herbert Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression Eur. J. Neurosci. 16 2002 445 453
33. L. Zhang, Li Bs, W. Ma, J.L. Barker, Y.H. Chang, W. Zhao, and D.R. Rubinow Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways Brain Res. Mol. Brain Res. 98 2002 58 66
34. I. Charalampopoulos, C. Tsatsanis, E. Dermitzaki, V.I. Alexaki, E. Castanas, A.N. Margioris, and A. Gravanis Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins Proc. Nat. Acad. Sci. U.S.A. 101 2004 8209 8214
35. I. Pérez-Neri, S. Montes, C. Ojeda-López, J. Ramírez-Bermúdez, and C. Ríos Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1118 1130
36. E. Tamagno, M. Guglielmotto, P. Bardini, G. Santoro, A. Davit, D. Di Simone, O. Danni, and M. Tabaton Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress Neurobiol. Dis. 14 2003 291 301
37. C.C. Chen, and C.R. Parker Jr. Adrenal androgens and the immune system Semin. Reprod. Med. 22 2004 369 377
38. R. Hampl, O. Lapcík, M. Hill, J. Klak, A. Kasal, A. Novácek, I. Sterzl, J. Sterzl, and L. Stárka 7-Hydroxydehydroepiandrosterone - a natural antiglucocorticoid and a candidate for steroid replacement therapy? Physiol. Res. 49 2000 S107 S112
39. P. Zheng Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance Prog. Neurobiol. 89 2009 134 152
40. T. Maurice, A. Urani, V.L. Phan, and P. Romieu The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities Brain Res. Brain Res. Rev. 37 2001 116 132
41. W. Leowattana DHEAS as a new diagnostic tool Clin. Chim. Acta 341 2004 1 15
42. L. Chen, X.N. Dai, and M. Sokabe Chronic administration of dehydroepiandrosterone sulfate (DHEAS) primes for facilitated induction of long-term potentiation via sigma 1 (sigma1) receptor: optical imaging study in rat hippocampal slices Neuropharmacology 50 2006 380 392
43. M. Racchi, S. Govoni, S.B. Solerte, C.L. Galli, and E. Corsini Dehydroepiandrosterone and the relationship with aging and memory: a possible link with protein kinase C functional machinery Brain Res. Brain Res. Rev. 37 2001 287 293
44. R. Bergeron, C. de Montigny, and G. Debonnel Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors J. Neurosci. 16 1996 1193 1202
45. M. Park-Chung, A. Malayev, R.H. Purdy, T.T. Gibbs, and D.H. Farb Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites Brain Res. 830 1999 72 87
46. P.H. Jellinck, M. Kaufmann, A. Gottfried-Blackmore, B.S. McEwen, G. Jones, and K. Bulloch Selective conversion by microglia of dehydroepiandrosterone to 5-androstenediol-A steroid with inherent estrogenic properties J. Steroid Biochem. Mol. Biol. 107 2007 156 162
47. H. Mukai, N. Takata, H.T. Ishii, N. Tanabe, Y. Hojo, A. Furukawa, T. Kimoto, and S. Kawato Hippocampal synthesis of estrogens and androgens which are paracrine modulators of synaptic plasticity: synaptocrinology Neuroscience 138 2006 757 764
48. K. Yaffe, D. Barnes, K. Lindquist, J. Cauley, E.M. Simonsick, B. Penninx, S. Satterfield, T. Harris, and S.R. Cummings Health ABC Investigators. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort Neurobiol. Aging 28 2007 171 178
49. J. Ryan, F.Z. Stanczyk, L. Dennerstein, W.J. Mack, M.S. Clark, C. Szoeke, D. Kildea, and V.W. Henderson Hormone levels and cognitive function in postmenopausal midlife women Neurobiol. Aging 33 2012 1138 1147
50. S.T. Haden, J. Glowacki, S. Hurwitz, C. Rosen, and M.S. LeBoff Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women Calcif. Tissue Int. 66 2000 414 418
51. M. Maggio, E. Dall'Aglio, F. Lauretani, C. Cattabiani, G. Ceresini, P. Caffarra, G. Valenti, R. Volpi, A. Vignali, G. Schiavi, and G.P. Ceda The hormonal pathway to cognitive impairment in older men J. Nutr. Health Aging 16 2012 40 54
52. J. Trejo, J. Piriz, M.V. Llorens-Martin, A.M. Fernandez, M. Bolos, D. LeRoith, A. Nunez, and I. Torres-Aleman Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects Mol. Psychiatry 12 2007 1118 1128
53. C. Luppi, M. Fioravanti, B. Bertolini, M. Inguscio, A. Grugnetti, F. Guerriero, C. Rovelli, F. Cantoni, P. Guagnano, E. Marazzi, E. Rolfo, D. Ghianda, D. Levante, C. Guerrini, R. Bonacasa, and S.B. Solerte Growth factors decrease in subjects with mild to moderate Alzheimer's disease (AD): potential correction with dehydroepiandrosterone-sulphate (DHEAS) Arch. Gerontol. Geriatr. 49 2009 173 184
54. G. Murialdo, A. Barreca, F. Nobili, A. Rollero, G. Timossi, M.V. Gianelli, F. Copello, G. Rodriguez, and A. Polleri Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia J. Endocrinol. Invest. 24 2001 139 146
55. A.J. Morales, J.J. Nolan, J.C. Nelson, and S.S. Yen Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age J. Clin. Endocrinol. Metab. 78 1994 1360 1367 (Erratum in: J. Clin. Endocrinol. Metab. 1995; 80:2799)
56. M.D. Majewska, S. Demirgören, C.E. Spivak, and E.D. London The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor Brain Res. 526 1990 143 146
57. J.M. Abadie, B. Wright, G. Correa, E.S. Browne, J.R. Porter, and F. Svec Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. The Obesity Research Program Diabetes 42 1993 662 669
58. M.D. Majewska Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance Prog. Neurobiol. 38 1992 379 395
59. A. Sousa, and M.K. Ticku Interactions of the neurosteroid dehydroepiandrosterone sulfate with the GABA(A) receptor complex reveals that it may act via the picrotoxin site J. Pharmacol. Exp. Ther. 282 1997 827 833
60. D.A. Meyer, M. Carta, L.D. Partridge, D.F. Covey, and C.F. Valenzuela Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic sigma1-like receptors J. Biol. Chem. 277 2002 28725 28732
61. M. Kano Plasticity of inhibitory synapses in the brain: a possible memory mechanism that has been overlooked Neurosci. Res. 21 1995 177 182
62. L.Y. Dong, Z.X. Cheng, Y.M. Fu, Z.M. Wang, Y.H. Zhu, J.L. Sun, Y. Dong, and P. Zheng Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and sigma-1 receptor Neuropharmacology 52 2007 966 974
63. P.E. Gold Acetylcholine modulation of neural systems involved in learning and memory Neurobiol. Learn. Mem. 80 2003 194 210
64. O. George, M. Vallée, M. Le Moal, and W. Mayo Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age-related changes Psychopharmacology (Berlin) 186 2006 402 413
65. N. Maninger, O.M. Wolkowitz, V.I. Reus, E.S. Epel, and S.H. Mellon Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) Front. Neuroendocrinol. 30 2009 65 91
66. J.S. Dillon Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders Curr. Drug Targets Inflamm. Allergy 4 2005 377 385
67. J.D. Weaver, M.H. Huang, M. Albert, T. Harris, J.W. Rowe, and T.E. Seeman Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging Neurology 59 2002 371 378
68. H.Y. Chung, M. Cesari, S. Anton, E. Marzetti, S. Giovannini, A.Y. Seo, C. Carter, B.P. Yu, and C. Leeuwenburgh Molecular inflammation: underpinnings of aging and age-related diseases Ageing Res. Rev. 8 2009 18 30
69. K.L. Hildreth, W.S. Gozansky, C.M. Jankowski, J. Grigsby, P. Wolfe, and W.M. Kohrt Association of serum dehydroepiandrosterone sulfate and cognition in older adults: sex steroid, inflammatory, and metabolic mechanisms Neuropsychology 27 2013 356 363
70. T. Sunderland, C.R. Merril, M.G. Harrington, B.A. Lawlor, S.E. Molchan, R. Martinez, and D.L. Murphy Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease Lancet 2 1989 570
71. A. Cardounel, W. Regelson, and M. Kalimi Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action Proc. Soc. Exp. Biol. Med. 222 1999 145 149
72. S. Bastianetto, C. Ramassamy, J. Poirier, and R. Quirion Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage Brain Res. Mol. Brain Res. 66 1999 35 41
73. A. Urani, A. Privat, and T. Maurice The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors Brain Res. 799 1998 64 77
74. J.H. Meyer, S. Lee, G.F. Wittenberg, R.D. Randall, and D.L. Gruol Neurosteroid regulation of inhibitory synaptic transmission in the rat hippocampus in vitro Neuroscience 90 1999 1177 1183
75. M. Wang Neurosteroids and GABA-A receptor function Front. Endocrinol. (Lausanne) 2 2011 44
76. D.M. Diamond, B.J. Branch, and M. Fleshner The neurosteroid dehydroepiandrosterone sulfate (DHEAS) enhances hippocampal primed burst, but not long-term, potentiation Neurosci. Lett. 202 1996 204 208
77. T. Maurice, T.P. Su, and A. Privat Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism Neuroscience 83 1998 413 428
78. A.L. Gundlach, B.L. Largent, and S.H. Snyder Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine J. Neurosci. 6 1986 1757 1770
79. K.L. Jansen, R.L. Faull, M. Dragunow, and R.A. Leslie Autoradiographic distribution of sigma receptors in human neocortex, hippocampus, basal ganglia, cerebellum, pineal and pituitary glands Brain Res. 559 1991 172 177
80. G. Alonso, V.L. Phan, I. Guillemain, M. Saunier, A. Legrand, M. Anoal, and T. Maurice Immunocytochemical localization of the sigma1 (σ1) receptor in the adult rat central nervous system Neuroscience 97 2000 155 170
81. T. Maurice, V.L. Phan, A. Urani, and I. Guillemain Differential involvement of the sigma(1) (sigma(1)) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse Br. J. Pharmacol. 134 2001 1731 1741
82. V.G. Kimonides, M.G. Spillantini, M.V. Sofroniew, J.W. Fawcett, and J. Herbert Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase C in hippocampal primary cultures Neuroscience 89 1999 429 436
83. V.G. Kimonides, N.H. Khatibi, C.N. Svendsen, M.V. Sofroniew, and J. Herbert Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity Proc. Nat. Acad. Sci. U.S.A. 95 1998 1852 1857
84. T.A. Salthouse The processing-speed theory of adult age differences in cognition Psychol. Rev. 103 1996 403 428
85. K.G. Sorwell, and H.F. Urbanski Dehydroepiandrosterone and age-related cognitive decline Age (Dordrecht) 32 2010 61 67
86. F. Magri, L. Cravello, L. Barili, S. Sarra, W. Cinchetti, F. Salmoiraghi, G. Micale, and E. Ferrari Stress and dementia: the role of the hypothalamicpituitary-adrenal axis Aging Clin. Exp. Res. 18 2006 167 170
87. G. Murialdo, F. Nobili, A. Rollero, M.V. Gianelli, F. Copello, G. Rodriguez, and A. Polleri Hippocampal perfusion and pituitary-adrenal axis in Alzheimer's disease Neuropsychobiology 42 2000 51 57
88. G. Valenti, L. Ferrucci, F. Lauretani, G. Ceresini, S. Bandinelli, M. Luci, G. Ceda, M. Maggio, and R.S. Schwartz Dehydroepiandrosterone sulfate and cognitive function in the elderly: the InCHIANTI study J. Endocrinol. Invest. 32 2009 766 772
89. M.T. Haren, W.A. Banks, H.M. Perry Iii, P. Patrick, T.K. Malmstrom, D.K. Miller, and J.E. Morley Predictors of serum testosterone and DHEAS in African-American men Int. J. Androl. 31 2008 50 59
90. S.R. Davis, S.M. Shah, D.P. McKenzie, J. Kulkarni, S.L. Davison, and R.J. Bell Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women J. Clin. Endocrinol. Metab. 93 2008 801 808
91. M.F. Morrison, I.R. Katz, P. Parmelee, A.A. Boyce, and T. TenHave Dehydroepiandrosterone sulfate (DHEA-S) and psychiatric and laboratory measures of frailty in a residential care population Am. J. Geriatr. Psychiatry 6 1998 277 284
92. M.F. Morrison, E. Redei, T. TenHave, P. Parmelee, A.A. Boyce, P.S. Sinha, and I.R. Katz Dehydroepiandrosterone sulfate and psychiatric measures in a frail, elderly residential care population Biol. Psychiatry 47 2000 144 150
93. B. Breuer, C. Martucci, S. Wallenstein, A. Likourezos, L.S. Libow, A. Peterson, and B. Zumoff Relationship of endogenous levels of sex hormones to cognition and depression in frail, elderly women Am. J. Geriatr. Psychiatry 10 2002 311 320
94. S.J. Fonda, R. Bertrand, A. O'Donnell, C. Longcope, and J.B. McKinlay Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study J. Gerontol. A Biol. Sci. Med. Sci. 60 2005 385 390
95. N. Goldman, and D.A. Glei Sex differences in the relationship between DHEAS and health Exp. Gerontol. 42 2007 979 987
96. J.L. Sanders, A.R. Cappola, A.M. Arnold, R.M. Boudreau, P.H. Chaves, J. Robbins, M. Cushman, and A.B. Newman Concurrent change in dehydroepiandrosterone sulfate and functional performance in the oldest old: results from the Cardiovascular Health Study All Stars study J. Gerontol. A Biol. Sci. Med. Sci. 65 2010 976 981
97. C. Berr, S. Lafont, B. Debuire, J.F. Dartigues, and E.E. Baulieu Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study Proc. Nat. Acad. Sci. U.S.A. 93 1996 13410 13415
98. K. Yaffe, B. Ettinger, A. Pressman, D. Seeley, M. Whooley, C. Schaefer, and S. Cummings Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study Biol. Psychiatry 43 1998 694 700
99. S.D. Moffat, A.B. Zonderman, S.M. Harman, M.R. Blackman, C. Kawas, and S.M. Resnick The relationship between longitudinal declines in dehydroepiandrosterone sulfate concentrations and cognitive performance in older men Arch. Intern. Med. 160 2000 2193 2198
100. E. Barrett-Connor, and S.L. Edelstein A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study J. Am. Geriatr. Soc. 42 1994 420 423
101. S. Kalmijn, L.J. Launer, R.P. Stolk, F.H. de Jong, H.A. Pols, A. Hofman, M.M. Breteler, and S.W. Lamberts A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly J. Clin. Endocrinol. Metab. 83 1998 3487 3492
102. L. Mazat, S. Lafont, C. Berr, B. Debuire, J.F. Tessier, J.F. Dartigues, and E.E. Baulieu Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality Proc. Nat. Acad. Sci. U.S.A. 98 2001 8145 8150
103. E. Ferrari, L. Cravello, F. Falvo, L. Barili, S.B. Solerte, M. Fioravanti, and F. Magri Neuroendocrine features in extreme longevity Exp. Gerontol. 43 2008 88 94
104. B.K. Lee, T.A. Glass, M.J. McAtee, G.S. Wand, K. Bandeen-Roche, K.I. Bolla, and B.S. Schwartz Associations of salivary cortisol with cognitive function in the Baltimore memory study Arch. Gen. Psychiatry 64 2007 810 818
105. H.C. Comijs, L. Gerritsen, B.W. Penninx, M.A. Bremmer, D.J. Deeg, and M.I. Geerlings The association between serum cortisol and cognitive decline in older persons Am. J. Geriatr. Psychiatry 18 2010 42 50
106. J.K. van Niekerk, F.A. Huppert, and J. Herbert Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation Psychoneuroendocrinology 26 2001 591 612
107. R.G. Masera, P. Prolo, M.L. Sartori, A. Staurenghi, G. Griot, and L. Ravizza Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease Psychoneuroendocrinology 27 2002 447 461
108. D. Armanini, F. Vecchio, A. Basso, F.F. Milone, M. Simoncini, C. Fiore, M.J. Mattarello, P. Sartorato, and I. Karbowiak Alzheimer's disease: pathophysiological implications of measurement of plasma cortisol, plasma dehydroepiandrosterone sulfate, and lymphocytic corticosteroid receptors Endocrine 22 2003 113 118
109. M. Markowski, M. Ungeheuer, D. Bitran, and C. Locurto Memory-enhancing effects of DHEAS in aged mice on a win-shift water escape task Physiol. Behav. 72 2001 521 525
110. N. Bélanger, L. Grégoire, P.J. Bédard, and T. Di Paolo DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys Neurobiol. Aging 27 2006 1684 1693
111. O.T. Wolf, B.M. Kudielka, D.H. Hellhammer, J. Hellhammer, and C. Kirschbaum Opposing effects of DHEA replacement in elderly subjects on declarative memory and attention after exposure to a laboratory stressor Psychoneuroendocrinology 23 1998 617 629
112. W. Arlt, J. Haas, F. Callies, M. Reincke, D. Hübler, M. Oettel, M. Ernst, H.M. Schulte, and B. Allolio Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens J. Clin. Endocrinol. Metab. 84 1999 2170 2176
113. P. Merritt Administration of dehydroepiandrosterone (DHEA) increases serum levels of androgens and estrogens but does not enhance short-term memory in post-menopausal women Brain Res. 1483 2012 54 62
114. E. Hirshman, E. Wells, M.E. Wierman, B. Anderson, A. Butler, M. Senholzi, and J. Fisher The effect of dehydroepiandrosterone (DHEA) on recognition memory decision processes and discrimination in postmenopausal women Psychon. Bull. Rev. 10 2003 125 134
115. B. Stangl, E. Hirshman, and J. Verbalis Administration of dehydroepianrosterone (DHEA) enhances visualspatial processing in post-menopausal women Behav. Neurosci. 125 2011 742 752
116. T.D. Parsons, K.M. Kratz, E. Thompson, F.Z. Stanczyk, and J.G. Buckwalter Dhea supplementation and cognition in postmenopausal women Int. J. Neurosci. 116 2006 141 155
117. O.T. Wolf, E. Naumann, D.H. Hellhammer, and C. Kirschbaum Effects of dehydroepiandrosterone replacement in elderly men on event-related potentials, memory, and well-being J. Gerontol. A Biol. Sci. Med. Sci. 53 1998 M385 M390
118. W. Arlt, F. Callies, I. Koehler, J.C. van Vlijmen, M. Fassnacht, C.J. Strasburger, M.J. Seibel, D. Huebler, M. Ernst, M. Oettel, M. Reincke, H.M. Schulte, and B. Allolio Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion J. Clin. Endocrinol. Metab. 86 2001 4686 4692
119. O.T. Wolf, O. Neumann, D.H. Hellhammer, A.C. Geiben, C.J. Strasburger, R.A. Dressendörfer, K.M. Pirke, and C. Kirschbaum Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men J. Clin. Endocrinol. Metab. 82 1997 2363 3367
120. D. Kritz-Silverstein, D. von Muhlen, G.A. Laughlin, and R. Bettencourt Effects of dehydroepiandrosteronesupplements on cognition function and quality of life: the DHEA and well-ness (DAWN) trial J. Am. Geriatr. Soc. 56 2008 1292 1298
121. S. Legrain, and L. Girard Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects Drugs Aging 20 2003 949 967
122. T. Azuma, Y. Nagai, T. Saito, M. Funauchi, T. Matsubara, and S. Sakoda The effect of dehydroepiandrosterone sulfate administration to patients with multi-infarct dementia J. Neurol. Sci. 162 1999 69 73
123. F. Bernardi, A. Lanzone, R.M. Cento, R.S. Spada, I. Pezzani, A.D. Genazzani, S. Luisi, M. Luisi, F. Petraglia, and A.R. Genazzani Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia Eur. J. Endocrinol. 142 2000 466 471
124. T. Yanase, M. Fukahori, S. Taniguchi, Y. Nishi, Y. Sakai, R. Takayanagi, M. Haji, and H. Nawata Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia Endocr. J. 43 1996 119 123
125. E. Ferrario, M. Massaia, G. Aimo, A. Pallavicino di Ceva, and F. Fabris Dehydroepiandrosterone sulfate serum levels: no significance in diagnosing Alzheimer's disease J. Endocrinol. Invest. 22 1999 81
126. M. Bo, M. Massaia, P. Zannella, G. Cappa, E. Ferrario, I. Rainero, E. Arvat, R. Giordano, and M. Molaschi Dehydroepiandrosterone sulfate (DHEA-S) and Alzheimer's dementia in older subjects Int. J. Geriatr. Psychiatry 21 2006 1065 1070
127. J.C. Naylor, C.M. Hulette, D.C. Steffens, L.J. Shampine, J.F. Ervin, V.M. Payne, M.W. Massing, J.D. Kilts, J.L. Strauss, P.S. Calhoun, R.P. Calnaido, and D.G. Blazer Lieberman JA,Madison RD, Marx CE. Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage J. Clin. Endocrinol. Metab. 93 2008 3173 3178
128. S.B. Kim, M. Hill, Y.T. Kwak, R. Hampl, D.H. Jo, R. Morfin, and 1. Neurosteroids: Cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics J. Clin. Endocrinol. Metab. 88 2003 5199 5206
129. S. Genedani, G. Rasio, P. Cortelli, F. Antonelli, D. Guidolin, M. Galantucci, K. Fuxe, and L.F. Agnati Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients Neurotox. Res. 6 2004 327 332
130. R.C. Brown, Z. Han, C. Cascio, and V. Papadopoulos Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology Neurobiol. Aging 24 2003 57 65
131. S. Yamada, M. Akishita, S. Fukai, S. Ogawa, K. Yamaguchi, J. Matsuyama, K. Kozaki, K. Toba, and Y. Ouchi Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment Geriatr. Gerontol. Int. 10 2010 280 287
132. O.M. Wolkowitz, J.H. Kramer, V.I. Reus, M.M. Costa, K. Yaffe, P. Walton, M. Raskind, E. Peskind, P. Newhouse, D. Sack, E. De Souza, C. Sadowsky, E. Roberts DHEA-Alzheimer's Disease Collaborative Research Group DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study Neurology 60 2003 1071 1076
133. J. Grimley Evans, R. Malouf, F.A.H. Huppert, and J.K. Van Niekerk Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people Cochrane Database Syst. Rev. 18 2006 CD006221
134. K.T. Barnhart, E. Freeman, J.A. Grisso, D.J. Rader, M. Sammel, S. Kapoor, and J.E. Nestler The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life J. Clin. Endocrinol. Metab. 84 1999 3896 3902
135. GISEG (Italian Study Group on Geriatric Endocrinology) G. Valenti, L. Denti, M. Saccò, G. Ceresini, S. Bossoni, A. Giustina, D. Maugeri, G.B. Vigna, R. Fellin, G. Paolisso, M. Barbagallo, M. Maggio, F. Strollo, L. Bollanti, F. Romanelli, and M. Latini Consensus document on substitution therapy with DHEA in the elderly Aging Clin. Exp. Res. 18 2006 277 300
136. M. Maggio, F. Lauretani, F. De Vita, S. Basaria, G. Lippi, V. Buttò, M. Luci, C. Cattabiani, G. Ceresini, I. Verzicco, L. Ferrucci, and G.P. Ceda Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons Curr. Pharm. Des. 2013 [PubMed: 24050169]
137. M. Maggio, F. Lauretani, G.P. Ceda, S. Bandinelli, S.M. Ling, E.G. Metter, A. Artoni, L. Carassale, A. Cazzato, G. Ceresini, J.M. Guralnik, S. Basaria, G. Valenti, and L. Ferrucci Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study Arch. Intern. Med. 167 2007 2249 2254